Ricketwil, Switzerland

Robert Waibel


Average Co-Inventor Count = 4.2

ph-index = 1


Location History:

  • Ricketwil, CH (2009)
  • Raeterschen, CH (2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert Waibel: Pioneering Therapeutics for Neoplastic Diseases

Introduction

Robert Waibel, an inventive mind hailing from Ricketwil, Switzerland, has made significant contributions in the fields of biotechnology and pharmaceuticals. With a remarkable portfolio of two patents, he stands as a testament to modern innovation, particularly in developing therapeutic agents targeting neoplastic diseases.

Latest Patents

Waibel's most recent patents showcase his dedication to advancing medical science. The first patent, titled "DIbarnase-barstar complexes," describes a complex where barnase is bound with high affinity to barstar, incorporating a therapeutic and/or diagnostic agent. This innovation holds promise for enhancing treatment modalities in various medical applications.

His second patent, "Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation," creatively addresses the limitations of traditional vitamin B12 therapies. The cobalamin derivatives presented in this invention exhibit low binding affinity to transcobalamin II (TCII) while retaining their activity as vitamin B12 substitutes. This approach aims to reduce the accumulation in benign organs like the kidney and liver, offering a tailored method for treating neoplastic diseases and infections by microorganisms, minimizing the risk of resistant offspring in neoplastic tissues.

Career Highlights

Robert Waibel has collaborated with notable institutions, contributing his expertise while working at the Paul Scherrer Institute and Solidago Ag. His work at these organizations reflects his commitment to applying scientific research to real-world healthcare challenges.

Collaborations

Throughout his career, Waibel has had the opportunity to collaborate with esteemed colleagues such as Hans-Jörg Treichler and Roger Alberto. These partnerships have played a crucial role in fostering innovation and introducing groundbreaking therapeutic solutions to the medical field.

Conclusion

Robert Waibel's inventive spirit and dedication to addressing complex medical issues display the impact that targeted therapeutic innovations can yield. His work continues to inspire future generations of inventors and researchers striving to make meaningful advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…